TCL Archive Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate April 25, 2014
TCL Archive Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds December 26, 2008
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983